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Introduction
The number of patients with HIV/TB alliance has
increased recently. There were 1055 TB/HIV cases
registered in European Union (6% out of 17 650 TB
cases tested for HIV) in 2010, among them 71 in Latvia
(9.5% out of all TB cases in 2010, in comparison with
0.5% in 2000). The treatment for TB/HIV cases is pro-
vided in Latvia according to WHO recommendations,
including DOTS strategy. However the TB treatment
results for HIV positive cases are concerning due to
increasing resistance to HIV/AIDS drugs and to TB
drugs.
Methods
The treatment results for 7761 new smear and/or cul-
ture positive pulmonary TB cases were analyzed, 234
among them were HIV positive. In HIV/AIDS naive
patients in general the resistance is found in 5.3% of
cases. In treated patients the resistance to different
groups of drugs is detected in 41% of cases: to all -3%,
to NRTI – 14%, to NRTI+NNRTI – 9%, to NRTII+PL –
6%, to NNRTI – 6%, to NNRTI+PI – 1%, to PI – 2%.
Multidrug resistance (MDR) was diagnosed in 14% of
TB cases. Molecular biological, immunofluorescence,
bacteriological and bacterioscopic methods were used
for detection of initiating agents. The TB treatment
results for HIV positive and HIV negative cases from
the period 2000-2007 were compared with the results
reported in 2010. Data for 2000-2007 was grouped
together due to small number of HIV positive cases
within the period.
Results
The treatment success for HIV positive cases was lower
in both periods (60-61%) in comparison with HIV nega-
tive cases (78-76%). The level of MDR TB cases among
HIV positive patients was higher (15%) than in HIV
negative patients (8%) during the years 2000-2007, but
similar in both groups (9-10,6%) in 2010. Despite
improvements in HIV/AIDS treatment since 2000, the
death rate among HIV positive cases in 2010 was higher
(18%) than during the years 2000-2007 (11%).
Conclusions
The resistance to HIV/AIDS drugs is a factor influen-
cing the TB treatment results.
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